Description
Ceftazidime 1g + Tazobactam 125mg Injection
Farlex Critical Care introduces Ceftazidime 1g + Tazobactam 125mg Injection, a potent combination antibiotic used to treat severe bacterial infections. Ceftazidime, a third-generation cephalosporin, provides broad-spectrum activity, while Tazobactam, a beta-lactamase inhibitor, enhances its effectiveness against resistant bacteria.
Our Ceftazidime 1g + Tazobactam 125mg Injection is manufactured in advanced facilities that adhere to strict quality standards, ensuring both safety and efficacy. As one of the Top Critical Care Pcd Companies in India, Farlex Critical Care is committed to delivering high-quality pharmaceutical products and Pcd opportunities to healthcare professionals.
Key Benefits:
- Broad-Spectrum Antibiotic: Effective against a wide range of bacterial infections.
- Enhanced Potency: Tazobactam prevents the breakdown of Ceftazidime by beta-lactamase enzymes.
- High-Quality Production: Manufactured in ISO and GMP certified facilities.
- Trusted Provider: Farlex Critical Care is a reputable name in the critical care pharmaceutical industry.
Applications:
Ceftazidime 1g + Tazobactam 125mg Injection is used to treat severe bacterial infections such as pneumonia, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. Always consult a healthcare professional before use.
Why Choose Farlex Critical Care?
- We are recognized as one of the Top Critical Care Pcd Companies in India.
- We provide high-quality products and comprehensive support to healthcare professionals.
- Our commitment to excellence ensures the best possible treatments are available.
For more information or to partner with us, contact Farlex Critical Care today.
